Health Catalyst, Inc (HCAT) Financials
HCAT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 701.8 million | 334.9 million |
2023-09-30 | 712.9 million | 330.5 million |
2023-06-30 | 722.9 million | 333.0 million |
2023-03-31 | 752.3 million | 347.2 million |
HCAT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -22.1 million | 13.0 million |
2023-09-30 | 6000 | 14.2 million |
2023-06-30 | -16.4 million | 14.6 million |
2023-03-31 | -9.0 million | 13.9 million |
HCAT Net Income
No data available :(
HCAT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 317.7 million | - | 21.0 million |
2023-09-30 | 347.7 million | - | 21.6 million |
2023-06-30 | 343.8 million | 227.3 million | 22.2 million |
2023-03-31 | 356.9 million | 226.9 million | 20.8 million |
HCAT Shares Outstanding
HCAT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 3.0 million | 17.0 million | 15.4 million | 17.3 million |
2023-09-30 | 3.1 million | 17.7 million | 13.6 million | 15.1 million |
2023-06-30 | 4.8 million | 17.6 million | 23.7 million | 16.4 million |
2023-03-31 | 3.4 million | 17.1 million | 23.8 million | 18.6 million |
HCAT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 75.1 million | 52.8 million |
2023-09-30 | 73.8 million | 41.8 million |
2023-06-30 | 73.2 million | 39.4 million |
2023-03-31 | 73.9 million | 38.3 million |
HCAT
Price: $6.95
52 week price:
Earnings Per Share: -2.09 USD
P/E Ratio: -4.51
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Volume: 258764
Market Capitalization: 385.3 million